COVID-19 Genomics UK Consortium
The current COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.
COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and over twelve academic partners providing sequencing and analysis capacity.
COG-UK is supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation.
News and Blogs
Commentary: COG-UK report 9 - 25th June 2020
The COVID-19 Genomics UK (COG-UK) Consortium has now sequenced more than 32,000 SARS-CoV-2 virus genomes from the UK. In the 9th report from the Consortium, dated 25th June, 29,593 of these were analysed
Explainer: The COVID-19 genome
Information from the genome sequences will help track the spread of the coronavirus in the UK and support public health planning and clinical decision making
COG-UK preliminary analysis reveals the frequency and source of virus introductions into the UK
The latest analysis of the COVID-19 epidemic in the UK combines large-scale data and genomic sequencing to provide a detailed picture of the number and sources of SARS-CoV-2 introductions into the UK